Media
Defining New Biology at the Intersection of Mitochondria and UPS
Events
Eminent immuno-oncologist, Dr. Wayne Hancock, joins Progenra Inc’s Scientific Advisory Board
MALVERN, PA August 15, 2014 – Progenra, Inc. announced today that Dr. Wayne Hancock, Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine has joined their Scientific
Society for Laboratory Automation and Screening – Washington DC, 2015
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took
American Association for Cancer Research – Philadelphia, 2015
AACR Annual Meeting 2015 April 18-22, 2015 Pennsylvania Convention Center Philadelphia, Pennsylvania Program Committee Chairperson Lewis C. Cantley, Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New
Publications
Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodeling after myocardial infarction: role of PR-364. Lizhuo Ai, Juliana de Freitas Germano, Chengqun Huang, Marianne Aniag, Savannah Sawaged, Jon Sin, Reetu Thakur, Deepika Rai, Christopher Rainville, David E. Sterner, Yang Song, Honit Piplani, Suresh Kumar, Tauseef R. Butt, Robert M. Mentzer, Aleksandr Stotland, Roberta A. Gottlieb, Jennifer E. Van Eyk. European Heart Journal., 2025 Jan 21;46(4):380-393. doi: 10.1093/eurheartj/ehae782 PMID: 39601359
A Method to Monitor Activity of SARS-CoV-2 Nsp3 from Cells. Christopher Rainville, David E. Sterner and Kumar Suresh. Methods Mol. Biol., 2023;2591:269-282. doi: 10.1007/978-1-0716-2803-4_16. PMID: 36350554.
Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2. Brian C. Sanders, Suman Pohkrel, Audrey D. Labbe, Irimpan I. Mathews, Connor J. Cooper, Russell B. Davidson, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Hugh O’Neill, Manat Kaur, Lori Ferrins, Jurgen G. Schmidt, Walter Reichard, Surekha Surendranathan, Jyothi Parvathareddy, Lexi Phillips, Christopher Rainville, David E. Sterner, Desigan Kumaran, Babak Andi, Gyorgy Babnigg, Nigel W. Moriarty, Paul D. Adams, Andrzej Joachimiak, Brett L. Hurst, Suresh Kumar, Tauseef R. Butt, Colleen B. Jonsson, Soichi Wakatsuki, Stephanie Galanie, Martha S. Head, and Jerry M. Parks. Nature Communications. 14, Article number: 1733 (2023)
Press Release
A New Parkinson’s Disease Drug Function in Inherited form of Parkinson’s Disease
Breakthrough Discovery Offers Hope for Precision Therapy in Mitochondrial Dysfunction Disorders
Progenra is disclosing its PINK1/parkin mol glues program at the, “PINK1 pathway to Parkinson’s disease: 20 years on”, Dr. Tauseef Butt will speak at the meetings organized by (British) The Biochemical Society, London, England, Nov 26-27, 2024.
Progenra, Inc. is invited to speak at 4th TPD Europe Summit: TPD for Drug Development March 19-21, 2024, London. Dr. Butt will speak on the topic of “Molecular Glues, Better Options than PROTACs, Parkin Ligase, Parkinson’s Disease and Beyond”.
Dr. Tauseef Butt, PhD, President & CEO, Progenra, Inc. is invited to speak at CHI Drug Discovery Chemistry, April 1-4, 2024, San Diego, CA. Dr. Butt will speak about Progenra’s efforts in developing novel molecular glues to treat neurodegenerative diseases.
Dr. Tauseef Butt, PhD, President & CEO, Progenra, Inc. is invited to speak at the Sixth Edition of Pharma R&D Conference in Boston, MA, during February 26-28, 2024. Dr. Butt will speak on the topic of “Molecular Glues vs PROTACs, Parkin Ligase, Parkinson’s Disease and Beyond”.
Let’s Partner for Scientific Breakthroughs
Please contact Progenra Business Development for inquiries:
